A population-based case-control teratological study of furosemide treatment during pregnancy

Clinical Drug Investigation

Volumn 18, Issue 4, 1999, Pages 307-315

  Czeizel, Andrew E ^a,b   Rockenbauer, Magda ^a  

^a NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^b NONE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE;

ARTICLE; CASE CONTROL STUDY; CONGENITAL DISORDER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; TERATOGENESIS;

EID: 0032756935     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199918040-00007     Document Type: Article

References (23)

1. Gerber JG, Nies AS. Antihypertensive agents and the drug therapy of hypertension. In: Rall TW, Nies AS, Taylor P, editors. Goodman and Gilman's The Pharmacological Basis of Therapeutics. Oxford; Pergamon Press, 1990: 884-913
2. Freis ED. The efficacy and safety of diuretics in treating hypertension. Ann Intern Med 1995; 122: 233-6
3. Friedman JM, Polifka JE. The Effects of Drugs on the Fetus and Nursing Infant. Baltimore: Johns Hopkins University Press, 1996
4. Schardein JL. Chemically Induced Birth Defects. 2nd Ed. New York: Marcel Dekker, 1993
5. Briggs GG, Freeman RF, Yaffe SJ. Drugs in Pregnancy and Lactation. 4th Ed. Baltimore: Williams and Wilkins, 1994
6. Shepard TH. Catalog of teralogenic agents. 8th Ed. Baltimore: Johns Hopkins University Press, 1995
7. Robertson RT, Minsker DH, Bokelman DL, et al. Potassium loss as a causative factor for skeletal malformations in rats produced by indacrinone: A new investigational loop diuretic. Toxicol Appl Pharmacol 1981; 60: 142-50
8. Hayasaka I, Uchiyama K, Murakami K, et al. Teratogenicity of azosemide, a loop diuretic, in rats, mice and rabbits. Cong Anom 1984; 24: 111-21
9. Sterz H, Sponer G, Neubert P, et al. A postulated mechanism of β-sympathomimetic induction of rib and limb anomalies in rat fetuses. Teratology 1985; 31: 401-12
10. Nakatsuka T, Fujikake N, Hasebe M, et al. Effects of sodium bicarbonate and ammonium chloride on the incidence of furosemide-induced fetal skeletal anomaly, wavy ribs, in rat. Teratology 1993; 48: 139-47
11. Czeizel AE, Rácz J. Evaluation of drug intake during pregnancy in the Hungarian Case-Control Surveillance of Congenital Anomalies. Teratology 1990; 42: 505-12
12. Czeizel AE. The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 1997; 55: 299-305
13. Czeizel AE. The role of pharmacoepidemiology in pharmacovigilance: Rational drug use in pregnancy. Pharmacoepidemiol Drug Saf 1999; 8: S55-S67
14. StataCorp: STATA Statistical Software: Release 4.0 for Windows. Stata Corporation, College Station, Texas, 1997
15. Wladimiroff JW. Effect of furosemide on fetal urine production. Br J Obstet Gynaecol 1975; 82: 221-4
16. Barrett RJ, Rayburn WF, Barr Jr M. Furosemide (Lasix®) challenge test in assessing bilateral fetal hydronephrosis. Am J Obstet Gynecol 1983; 147: 846-7
17. Czeizel AE, Telegdi L, Tusnády G. Multiple Congenital Abnormalities. Akadémiai Kiadó. Budapest, 1998
18. Godde VE, Grote W. Animal experimental investigations on the dysionic genesis of intrauterine malformations [in German]. Arzneimittelforschung 1975; 25: 809-13
19. Mallie JP, Gerard A, Gerard H. Does the in-utero exposure to furosemide delay the renal maturation? Pediatr Pharmacol 1985; 5: 131-8
20. Guignard J-P. Effect of drugs on the immature kidney. Adv Nephrol 1993; 22: 193-211
21. Vert P, Broquaire M, Legagneur M, et al. Pharmacokinetics of furosemide in neonates. Eur J Clin Pharmacol 1982; 22: 39-45
22. Turmen T, Thom P, Louridas AT, et al. Protein binding and bilirubin displacing properties of bumetanide and furosemide. J Clin Pharmacol 1982; 22: 551-6
23. Harris JP, Alexson CG, Manning JA, et al. Medical therapy for the hydropic fetus with congenital complete atrioventricular block. Am J Perinatol 1993; 10(3): 217-9